Document:

Exhibit 4.8

 

Gain
Therapeutics Inc.

Stock Option grant notice

(2022
Equity Incentive Plan)

 

Gain Therapeutics
Inc. (the “Company”), pursuant to the Company’s 2022 Equity Incentive Plan (the “Plan”),
has granted to you (“Optionholder”) an option to purchase the number of shares of the Common
Stock set forth below (the “Option”). Your Option is subject to all of the terms and conditions as set forth
herein and in the Plan, and the Stock Option Agreement and the Notice of Exercise, all of which are attached hereto and incorporated
herein in their entirety. Capitalized terms not explicitly defined herein but defined in the Plan or the Stock Option Agreement shall
have the meanings set forth in the Plan or the Stock Option Agreement, as applicable.

 

	Optionholder:	
	Date of Grant:	
	Vesting Commencement Date:	
	Number of Shares of Common Stock Subject to Option:	
	Exercise Price (Per Share):	
	Total Exercise Price:	
	Expiration Date:	

 

		Type of Grant:	[Incentive
                                            Stock Option]1 OR [Nonstatutory Stock Option]

 

	Exercise and Vesting	Schedule:
  Subject to the Optionholder’s Continuous Service through each applicable vesting date, the Option will vest as follows:

 

		 	[_____________________________________________________________]

 

Optionholder
Acknowledgements: By your signature below or by electronic acceptance or authentication in a form authorized by the Company, you
understand and agree that:

 

		·	The
                                            Option is governed by this Stock Option Grant Notice (this “Grant Notice”),
                                            and the provisions of the Plan and the Stock Option Agreement and the Notice of Exercise,
                                            all of which are made a part of this document. Unless otherwise provided in the Plan, this
                                            Grant Notice and the Stock Option Agreement (together, the “Option Agreement”)
                                            may not be modified, amended or revised except in a writing signed by you and a duly authorized
                                            officer of the Company.

 

		·	If
                                            you are an employee of the Company and the Option is an Incentive Stock Option, it (plus
                                            other outstanding Incentive Stock Options granted to you) cannot be first exercisable
                                            for more than $100,000 in value (measured by exercise price) in any calendar year. Any
                                            excess over $100,000 is a Nonstatutory Stock Option.

 

		·	You
                                            consent to receive this Grant Notice, the Stock Option Agreement, the Plan, the document
                                            containing the Plan information specified in Section 10(a) of the Securities Act (the “Prospectus”),
                                            and any other Plan-related documents by electronic delivery and to participate in the Plan
                                            through an on-line or electronic system established and maintained by the Company or another
                                            third party designated by the Company.

 

 

1 If this is an Incentive Stock Option, it (plus other outstanding Incentive Stock
Options) cannot be first exercisable for more than $100,000 in value (measured by exercise price) in any calendar year. Any excess over
$100,000 is a Nonstatutory Stock Option.

 

    1

     

    

 

		·	You
                                            have read and are familiar with the provisions of the Plan, the Stock Option Agreement, the
                                            Notice of Exercise and the Prospectus. In the event of any conflict between the provisions
                                            in this Grant Notice, the Option Agreement, the Notice of Exercise, or the Prospectus and
                                            the terms of the Plan, the terms of the Plan shall control.

 

		·	The
                                            Option Agreement sets forth the entire understanding between you and the Company regarding
                                            the acquisition of Common Stock and supersedes all prior oral and written agreements, promises
                                            and/or representations on that subject with the exception of other equity awards previously
                                            granted to you and any written employment agreement, offer letter, severance agreement, written
                                            severance plan or policy, or other written agreement between the Company and you in each
                                            case that specifies the terms that should govern this Option.

 

		·	Counterparts
                                            may be delivered via facsimile, electronic mail (including pdf or any electronic signature
                                            complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or
                                            other applicable law) or other transmission method and any counterpart so delivered will
                                            be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

	Gain
    Therapeutics Inc.	 	Optionholder:
	 	 	 	 	 
	By: 	 	 	 
	 	Signature	 	 	Signature
	Title: 	 	 	Date: 	 
	 	 	 	 	 
	Date:	 	 	 	 

 

		Attachments:	Stock
                                            Option Agreement, 2022 Equity Incentive Plan, Notice of Exercise

 

     

     

    

 

Attachment
I

 

Gain
THERAPEUTICS Inc.

Stock Option Agreement

(2022
Equity Incentive Plan)

 

As
reflected by your Stock Option Grant Notice (“Grant Notice”), Gain Therapeutics Inc. (the “Company”)
has granted you an option under the Company’s 2022 Equity Incentive Plan (the “Plan”) to purchase a number
of shares of Common Stock at the exercise price indicated in your Grant Notice (the “Option”). Capitalized
terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan shall have the meanings set forth in the Grant
Notice or Plan, as applicable. The terms of your Option as specified in the Grant Notice and this Stock Option Agreement constitute your
Option Agreement.

 

The
general terms and conditions applicable to your Option are as follows:

 

1.                 
Governing Plan Document. Your Option is subject to all the provisions of the
Plan, including but not limited to the provisions in:

 

(a)              
Section 6 regarding the impact of a Capitalization Adjustment, dissolution, liquidation, or Corporate Transaction on your
Option;

 

(b)             
Section 9(e) regarding the Company’s retained rights to terminate your Continuous Service notwithstanding the grant
of the Option; and 

 

(c)              
Section 8 regarding the tax consequences of your Option. 

 

Your
Option is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted
pursuant to the Plan. In the event of any conflict between the Option Agreement and the provisions of the Plan, the provisions of the
Plan shall control.

 

2.                 
Vesting. Your Option will vest as provided in your Grant Notice, subject to
the provisions contained herein and the terms of the Plan. Vesting will cease upon the termination of your Continuous Service. [Notwithstanding
anything herein to the contrary, in the event that your Option is assumed, continued or substituted in connection with a Change in Control
and your Continuous Service is terminated on or after the effective date of the Change in Control but prior to twelve (12) months following
the Change in Control by the Company (or any successor or Affiliate thereof) without Cause or due to a resignation by you for Good Reason
(if applicable), any unvested portion of the assumed, continued or substituted Option will vest in full. For purposes of this Stock Option
Agreement, “Good Reason” shall have the meaning assigned to such term in any individual employment, service
or severance agreement between you and the Company; provided, that if no such agreement exists or if such agreement does not define “Good
Reason,” Good Reason and the provision above with respect to Good Reason shall not be applicable to you.]

 

3.                 
Exercise.

 

(a)              
You may generally exercise the vested portion of your Option for whole shares of Common Stock at any time during its term
by delivery of payment of the exercise price and applicable withholding taxes and other required documentation to the Plan Administrator
in accordance with the exercise procedures established by the Plan Administrator, which may include an electronic submission. Please
review Sections 4(i), 4(j) and 7(b)(v) of the Plan, which may restrict or prohibit your ability to exercise your Option during certain
periods.

 

     

     

    

 

(b)             
To the extent permitted by Applicable Law, you may pay your Option exercise price as follows:

 

(i)                
cash, check, bank draft or money order; 

 

(ii)             
pursuant to a “cashless exercise” program as further described in Section 4(c)(ii) of the Plan if at the time
of exercise the Common Stock is publicly traded;

 

(iii)           
subject to Company and/or Committee consent at the time of exercise, by delivery of previously owned shares of Common Stock
as further described in Section 4(c)(iii) of the Plan; or

 

(iv)            
subject to Company and/or Committee consent at the time of exercise, if the Option is a Nonstatutory Stock Option, by a “net
exercise” arrangement as further described in Section 4(c)(iv) of the Plan.

 

4.                 
Term. You may not exercise your Option before the commencement of its term or
after its term expires. The term of your Option commences on the Date of Grant and expires upon the earliest of the following:

 

(a)              
immediately upon the termination of your Continuous Service for Cause;

 

(b)             
three months after the termination of your Continuous Service for any reason other than Cause, Disability or death;

 

(c)              
12 months after the termination of your Continuous Service due to your Disability;

 

(d)             
18 months after your death if you die during your Continuous Service;

 

(e)              
immediately upon a Corporate Transaction if the Board has determined that the Option will terminate in connection with a Corporate
Transaction,

 

(f)               
the Expiration Date indicated in your Grant Notice; or

 

(g)              
the day before the 10th anniversary of the Date of Grant.

 

Notwithstanding
the foregoing, if you die during the period provided in Section 4(b) or 4(c) above, the term of your Option shall not expire until the
earlier of (i) 18 months after your death, (ii) upon any termination of the Option in connection with a Corporate Transaction, (iii)
the Expiration Date indicated in your Grant Notice, or (iv) the day before the tenth anniversary of the Date of Grant. Additionally,
the Post-Termination Exercise Period of your Option may be extended as provided in Section 4(i) of the Plan.

 

To
obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on
the date of grant of your Option and ending on the day three months before the date of your Option’s exercise, you must be an employee
of the Company or an Affiliate, except in the event of your death or Disability. If the Company provides for the extended exercisability
of your Option under certain circumstances for your benefit, your Option will not necessarily be treated as an Incentive Stock Option
if you exercise your Option more than three months after the date your employment terminates.

 

     

     

    

 

5.                 
Withholding Obligations. As further provided in Section 8 of the Plan: (a) you
may not exercise your Option unless the applicable tax withholding obligations are satisfied, and (b) at the time you exercise your Option,
in whole or in part, or at any time thereafter as requested by the Company, you hereby authorize withholding from payroll and any other
amounts payable to you, and otherwise agree to make adequate provision for (including by means of a “cashless exercise” pursuant
to a program developed under Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company), any sums
required to satisfy the federal, state, local and foreign tax withholding obligations, if any, which arise in connection with the exercise
of your Option in accordance with the withholding procedures established by the Company. Accordingly, you may not be able to exercise
your Option even though the Option is vested, and the Company shall have no obligation to issue shares of Common Stock subject to your
Option, unless and until such obligations are satisfied. In the event that the amount of the Company’s withholding obligation in
connection with your Option was greater than the amount actually withheld by the Company, you agree to indemnify and hold the Company
harmless from any failure by the Company to withhold the proper amount.

 

6.                 
Incentive Stock Option Disposition Requirement. If your Option is an Incentive
Stock Option, you must notify the Company in writing within 15 days after the date of any disposition of any of the shares of the Common
Stock issued upon exercise of your Option that occurs within two years after the date of your Option grant or within one year after such
shares of Common Stock are transferred upon exercise of your Option.

 

7.                 
Transferability. Except as otherwise provided in the Plan, your Option is not
transferable, except by will or by the applicable laws of descent and distribution, and is exercisable during your life only by you.

 

8.                 
Corporate Transaction. Your Option is subject to the terms of any agreement
governing a Corporate Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder
representative that is authorized to act on your behalf with respect to any escrow, indemnities and any contingent consideration.

 

9.                 
No Liability for Taxes. As a condition to accepting the Option, you hereby (a)
agree to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities
arising from the Option or other Company compensation and (b) acknowledge that you were advised to consult with your own personal tax,
financial and other legal advisors regarding the tax consequences of the Option and have either done so or knowingly and voluntarily
declined to do so. Additionally, you acknowledge that the Option is exempt from Section 409A only if the exercise price is at least equal
to the “fair market value” of the Common Stock on the date of grant as determined by the Internal Revenue Service and there
is no other impermissible deferral of compensation associated with the Option. Additionally, as a condition to accepting the Option,
you agree not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the Internal
Revenue Service asserts that such exercise is less than the “fair market value” of the Common Stock on the date of grant
as subsequently determined by the Internal Revenue Service.

 

10.             
Severability. If any part of this Option Agreement or the Plan is declared by
any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this
Option Agreement or the Plan not declared to be unlawful or invalid.  Any Section of this Option Agreement (or part of such
a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner which will give effect to the terms of such
Section or part of a Section to the fullest extent possible while remaining lawful and valid

 

     

     

    

 

11.             
Execution of Documents. You hereby acknowledge and agree that the manner selected
by the Company by which you indicate your consent to your Grant Notice is also deemed to be your execution of your Grant Notice and of
this Agreement. You further agree that such manner of indicating consent may be relied upon as your signature for establishing your execution
of any documents to be executed in the future in connection with your Option.

 

12.             
Other Documents.  You hereby acknowledge receipt of or the right to
receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Prospectus.  In
addition, you acknowledge receipt of the Company’s Trading Policy.

 

13.             
Effect on Other Employee Benefit Plans. The value of your Option shall not be
included as compensation, earnings, salaries, or other similar terms used when calculating benefits under any employee benefit plan (other
than the Plan) sponsored by the Company or any Affiliate except as such plan otherwise expressly provides. The Company expressly reserves
its rights to amend, modify, or terminate any or all of the employee benefit plans of the Company or any Affiliate.

 

14.             
Questions.  If you have questions regarding these or any other terms and conditions
applicable to your Option, including a summary of the applicable federal income tax consequences please see the Prospectus.

 

*
* * *

 

     

     

    

 

Attachment
II

 

Gain
THERAPEUTICS Inc. 

2022
Equity Incentive Plan

 

     

     

    

 

Attachment
III

 

Gain
THERAPEUTICS Inc.

notice of exercise

(2022
Equity Incentive Plan)

 

Gain
Therapeutics Inc.

4800 Montgomery
Lane, Suite 220

Bethesda, MD 20814

	(301) 500-1556	Date of Exercise: 	 

 

This
constitutes notice to Gain Therapeutics Inc. (the “Company”) that I elect to purchase the below number of shares
of Common Stock of the Company (the “Shares”) by exercising my Option for the price set forth below. Capitalized
terms not explicitly defined in this Notice of Exercise but defined in the Stock Option Grant Notice, Stock Option Agreement or 2022
Equity Incentive Plan (the “Plan”) shall have the meanings set forth in the Stock Option Grant Notice,
Stock Option Agreement or Plan, as applicable. Use of certain payment methods is subject to Company and/or Committee consent and certain
additional requirements set forth in the Stock Option Agreement and the Plan.

 

	 	Type of option (check
    one):	 	Incentive   ̈	Nonstatutory   ̈
	 	 	 	 	 
	 	Date of Grant:	 	                                   	 
	 	 	 	 	 
	 	Number of Shares as to which
    Option is exercised:	 	                                   	 
	 	 	 	 	 
	 	Certificates to be issued in
    name of:	 	                                   	 
	 	 	 	 	 
	 	Total exercise price:	 	$                           	 

 

	 	Cash, check, bank
    draft or money order delivered herewith:	 	$                           	 
	 	 	 	 	 
	 	Value of ________ Shares delivered
    herewith:	 	$                           	 
	 	 	 	 	 
	 	Regulation T Program (cashless
    exercise)	 	$                           	 
	 	 	 	 	 
	 	Value of _______ Shares pursuant
    to net exercise:	 	$                           	 

 

By
this exercise, I agree (i) to provide such additional documents as you may require pursuant to the terms of the Plan, the Stock
Option Grant Notice and the Stock Option Agreement, (ii) to satisfy the tax and/or social security withholding obligations, if any,
relating to the exercise of this Option as set forth in the Stock Option Agreement, and (iii) if this exercise relates to an incentive
stock option, to notify you in writing within 15 days after the date of any disposition of any of the Shares issued upon exercise of
this Option that occurs within two years after the Date of Grant or within one year after such Shares are issued upon exercise of this
Option.

 

	 	Very truly yours,EX-4.1

   

  SECOND LOAN EXTENSION AGREEMENT

  This SECOND LOAN EXTENSION AGREEMENT (this “Agreement”) is made as of June 30, 2022, by and among (i) EVO TRANSPORTATION & ENERGY SERVICES, INC., a Delaware corporation having its principal office at 2075 West Pinnacle Peak Rd., Suite 130, Phoenix AZ 85027 (“Borrower”), and each subsidiary of Borrower listed on the signature pages hereto or that after the date hereof delivers such a signature page (each a “Guarantor”, collectively, the “Guarantors” and, together with Borrower, the “Loan Parties” and each a “Loan Party”), (ii) ANTARA CAPITAL MASTER FUND LP and/or one or more managed funds or accounts (the “Lender”), and (iii) each lender listed on Schedule I of the Loan Agreement (as defined below) (each, an “Executive Lender” and together, the “Executive Lenders”). Capitalized terms used but not defined in this Agreement shall have the meanings given to them in the Loan Agreement or, to the extent not defined in this Agreement or the Loan Agreement, in the Certificate of Designations of Series C Non-Participating Preferred Stock of the Corporation, duly adopted by the Board of Directors of the Borrower on March 11, 2022.

  W I T N E S S E T H:

  WHEREAS, the Loan Parties are indebted to the Lender and the Executive Lenders pursuant to that certain Senior Secured Loan and Executive Loan Agreement dated as of March 11, 2022 (the “Original Loan Agreement”), as amended by the Loan Extension Agreement dated May 31, 2022 (the “Loan Extension Agreement” and the Original Loan Agreement as amended by the Loan Extension Agreement, the “Loan Agreement”).

  WHEREAS, the Loan Parties and the Lender wish to extend the “Maturity Date” (as defined in the Loan Agreement) of the Loan from June 30, 2022 to July 8, 2022 upon satisfaction of the terms and conditions set forth in this Agreement.

  WHEREAS, the Loan Parties and the Executive Lenders wish to extend the “Executive Loan Maturity Date” (as defined in the Loan Agreement) of the Executive Loans from July 7, 2022 to July 15, 2022 upon satisfaction of the terms and conditions set forth in this Agreement.

  WHEREAS, the parties to this Agreement (the “Parties”) desire to memorialize the aforementioned extensions as hereinafter set forth.

  NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements hereinafter set forth, the Parties hereby agree as follows:

  1.Extension of the Loan Maturity Date. Effective upon the date of this Agreement, the Loan Agreement is amended to extend the “Maturity Date” from (i) the earlier of (a) demand by the Lender on any day prior to the Collateral Pledge Effective Date and (b) June 30, 2022 to (ii) the earlier of (a) demand by the Lender on any day prior to the Collateral Pledge Effective Date and (b) July 8, 2022. 

  2.Extension of each Executive Loan Maturity Date. Effective upon the date of this Agreement, the Loan Agreement is amended to extend each “Executive Loan Maturity Date” from July 7, 2022 to July 15, 2022.

  		 

  

   

  1.Representations. The Loan Parties hereby represent and warrant to Lender and each Executive Lender as of the date hereof that each of the representations and warranties made by any Loan Party in the Loan Agreement have been and remain true and correct in all material respects as if remade on the date hereof, subject to changes to such representations and warranties set forth on Exhibit A attached hereto (the “Representation Updates”). None of the Representation Updates are the result of any breach of a covenant of any Loan Party under the Loan Agreement, nor do they result from or in any Event of Default. Neither the execution, delivery or performance of this Agreement nor any other agreement contemplated hereby will (a) violate any applicable law in any material respect, (b) violate the organizational documents of any Loan Party, or (c) breach, violate or result in a default, or give rise to a termination, cancellation, acceleration or other right or remedy, under any material agreement, instrument or other contractual obligation of any Loan Party.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  2.Additional Covenants. 

  a.The Loan Parties shall use their best efforts to execute and deliver, and/or cause to be executed and delivered, a “Loan Pledge Security Agreement” substantially in the form attached as Exhibit A to the Loan Extension Agreement and a “Bridge Loan Subordination Agreement” substantially in the form attached as Exhibit B to the Loan Extension Agreement, in each case with Lender acting as “Collateral Agent”, on or before July 8, 2022.

  3.Full Force and Effect. Except as specifically set forth herein, all of the terms and conditions of the Loan Agreement are unmodified and remain in full force and effect.  

  4.No Novation. The Parties do not intend the terms of this Agreement to be construed as a novation of any of the obligations owing by the Loan Parties under or in connection with the Loan or the Executive Loans.  

  5.Ratification and Affirmation of Guaranties and Indemnities. By the execution hereof, each Guarantor hereby acknowledges and agrees and consents to the terms of this Agreement and that, except as expressly provided in Section 1 and Section 2 of this Agreement, nothing contained herein shall modify, affect or otherwise diminish the obligations of Guarantor under the Loan Agreement applicable to such Guarantor, and each Guarantor hereby certifies, reaffirms and ratifies its obligations under the Loan Agreement.

  6.Release of Lender Liability. TO THE MAXIMUM EXTENT NOT PROHIBITED BY LAW FROM TIME TO TIME IN EFFECT, EACH LOAN PARTY HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY (AND AFTER IT HAS CONSULTED WITH ITS OWN COUNSEL) IRREVOCABLY AND UNCONDITIONALLY AGREES THAT NO CLAIM MAY BE MADE BY SUCH LOAN PARTY AGAINST THE LENDER OR ANY OF THE LENDER’S DIRECTORS, OFFICERS, EMPLOYEES, ATTORNEYS, ACCOUNTANTS, AGENTS OR INSURERS, OR ANY OF ITS OR THEIR SUCCESSORS AND ASSIGNS, FOR ANY SPECIAL, INDIRECT, CONSEQUENTIAL OR PUNITIVE DAMAGES IN RESPECT OF ANY BREACH OR WRONGFUL CONDUCT (WHETHER THE CLAIM IS BASED 

   

  

   

  ON CONTRACT OR TORT OR DUTY IMPOSED BY LAW) ARISING OUT OF, OR RELATED TO, THE TRANSACTIONS CONTEMPLATED BY ANY OF THIS AGREEMENT OR THE LOAN AGREEMENT, OR ANY ACT, OMISSION, OR EVENT OCCURRING IN CONNECTION HEREWITH OR THEREWITH. IN FURTHERANCE OF THE FOREGOING, EACH LOAN PARTY HEREBY WAIVES, RELEASES AND AGREES NOT TO SUE UPON ANY CLAIM FOR ANY SUCH DAMAGES, WHETHER OR NOT ACCRUED AND WHETHER OR NOT KNOWN OR SUSPECTED TO EXIST IN ITS FAVOR. 

  7.Counterparts. This Agreement may be executed in any number of counterparts (which may be electronic, including PDF) and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original and shall be binding upon all parties and their respective permitted successors and assigns, and all of which taken together shall constitute one and the same agreement.

  8.Governing Law. This Agreement shall be governed in accordance with the terms and provisions of Section 25 and Section 26 of the Original Loan Agreement, except, for purposes of this Agreement, references to “Loan Agreement” shall be deemed to refer to the Original Loan Agreement as modified by the Loan Extension Agreement and as further modified by this Agreement.

  [NO FURTHER TEXT ON THIS PAGE]

   

   

  

   

  IN WITNESS WHEREOF, each Loan Party has caused this Agreement to be duly executed as of the date set forth above.

  EVO TRANSPORTATION & ENERGY SERVICES, INC., as Borrower

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  W.E. GRAHAM, INC., as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  EVO LOGISTICS, LLC, as a Guarantor 

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  TITAN CNG LLC, as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  THUNDER RIDGE TRANSPORT, INC., as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  Signature Page to Loan Extension Agreement

  

   

  SHEEHY MAIL CONTRACTORS, INC., as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  URSA MAJOR CORPORATION, as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  J.B. LEASE CORPORATION, as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  EVO EQUIPMENT LEASING, LLC, as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  COURTLANDT AND BROWN ENTERPRISES L.L.C., as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  FINKLE TRANSPORT, INC., as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  Signature Page to Loan Extension Agreement

   

  

   

  EVO SERVICES GROUP, LLC, as a Guarantor

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood
Title:	Chief Executive Officer	

  	 

   

  Signature Page to Loan Extension Agreement

   

  

   

  AGREED TO AND ACCEPTED:

  ANTARA CAPITAL MASTER FUND LP (as Lender)

  By: Antara Capital Fund GP LLC, its General Partner 

   

  By:	/s/ Himanshu Gulati	
Name:	Himanshu Gulati
Title:	Managing Partner

   

  Executive Lenders

  AGREED TO AND ACCEPTED:

   

  By:	/s/ Thomas J. Abood	
Name:	Thomas J. Abood	

  AGREED TO AND ACCEPTED:

   

  By:	/s/ Damon R. Cuzick	
Name:	Damon R. Cuzick

  AGREED TO AND ACCEPTED:

  BRIDGEWEST GROWTH FUND LLC

   

  By:	/s/ Billy (Trey) Peck Jr.	
Name:	Billy (Trey) Peck Jr.

  Title:	Managing Member

   

  AGREED TO AND ACCEPTED:

  BATUTA CAPITAL ADVISORS LLC 

   

  By:	/s/ Alexandre Zyngier	
Name:	Alexandre Zyngier
Title:	Managing Director

  Signature Page to Loan Extension Agreement

   

  

   

   

  EXHIBIT A

   

   

  UPDATES TO REPRESENTATIONS AND WARRANTIES

   

   

  Omitted.

  EXHIBIT A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]